Emergent BioSolutions, Inc.
(NYSE : EBS)

( )
EBS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.10%39.960.9%$1280.47m
JNJJohnson & Johnson -0.05%170.110.7%$1252.84m
MRKMerck & Co., Inc. 0.10%78.300.7%$927.83m
ABBVAbbVie, Inc. -0.24%116.241.9%$719.29m
BMYBristol-Myers Squibb Co. -0.20%64.711.0%$718.11m
LLYEli Lilly & Co. -0.10%196.211.1%$572.98m
AZNAstraZeneca Plc 0.44%55.451.2%$533.98m
BTXBrooklyn ImmunoTherapeutics, Inc. -1.75%21.3112.8%$251.69m
GSKGlaxoSmithKline Plc 0.31%39.210.2%$192.02m
NVSNovartis AG -0.36%88.680.2%$173.01m
VTRSViatris, Inc. -0.81%15.870.0%$167.06m
CVACCureVac NV 0.76%110.830.0%$160.97m
NVONovo Nordisk A/S 0.22%79.280.1%$72.35m
SNYSanofi 0.40%52.950.2%$72.05m
MNMDMind Medicine (MindMed), Inc. 13.93%3.680.0%$65.23m

Company Profile

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.